Price $7.29 |
Market Cap
327.9M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
-
|
P/B
7.0
|
P/S
-
|
Dividend %
-
|
|
P/CF
-
|
P/FCF
-
|
Op. Cash Flow
-17.7K
|
FCF
-0.5
|
|
Op. Margin
-
|
Net Margin
-
|
ROE
-51.90%
|
ROI
-
|
|
ROA
-48.90%
|
EPS Growth
17.30%
|
Current Ratio
5.9
|
Debt/Equity
-
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| TearLab Corp (TEAR) | $0.08 | - | - | 1.1M | Strong Buy |
| Champions Oncology Inc (CSBR) | $7.81 | - | - | 110.8M | Strong Buy |
| R1 RCM Inc (RCM) | $12.10 | - | - | 1.32B | Strong Buy |
| ImmuCell Corporation (ICCC) | $6.54 | - | - | 44.5M | Strong Buy |
| PDL BioPharma Inc (PDLI) | $2.95 | - | - | 355.9M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
